Presentation Abstract

This session will be an interactive discussion of the key changes resulting from the implementation of healthcare reform, their timing and the implications for pharmaceutical manufacturers. A variety of topics will be covered, the likely impact of structural changes, higher government-mandated rebates from manufacturers, new state insurance exchanges, accountable care organizations (ACOs) and comparative efficacy reviews. These changes will be examined from a payer perspective, specifically how payers are likely to shift their organizational priorities, evaluate new products, and manage access with new restrictions. Participants will learn what are the key events, their likely implications and how to prepare for and respond to these changes. We will also briefly cover recent events that may impact some aspects of healthcare reform including judicial and legislative actions.

Speaker Biographies

John Robinson is a seasoned professional with over 26 years of market research experience, including 12 years conducting payer/access/pricing research among various stakeholders including MCOs/PBMs, hospitals, providers, healthcare professionals, retail pharmacists, patients and wholesalers. John has a comprehensive approach to the design and execution of payer research to fully meet his client’s needs. In addition, his long-standing experience and continued involvement with on-going payer/access/pricing conferences translates into keen awareness of current trends and events impacting the payer environment. This knowledge allows John to anticipate evolving trends in order to recommend appropriate research activities and discern insights so that his clients are better prepared to meet the challenges of an evolving payer marketplace.

Prior to joining Genactis, John founded and operated his own marketing research firm for 12 years that focused on managed markets, niche hospital markets and business-to-business research. John began his career at a strategic marketing consulting firm that was a pioneer in the use of conjoint analysis, simulation modeling and other multivariate techniques as the COO. He holds a M.S. in Marketing, a B.A. in Liberal Arts and a B.S. in Psychology, all from The Pennsylvania State University.